Articulo de referencia

Teva Canada

[[Toronto]], [[Ontario]] M1B 2K9"},"key_people":{"wt":""},"num_employees":{"wt":""},"industry":{"wt":"[[Health Care]]"},"products":{"wt":"[[Generic drug|Generic Pharmaceuticals]...

Teva Canada is one of Canada's largest generic pharmaceutical companies. The company was founded as Novopharm by Leslie Dan in 1965. After its acquisition by pharmaceutical giant Teva Pharmaceutical Industries in 2000, it was renamed Teva Novopharm. The Novopharm name was dropped in 2010, when it became Teva Canada.[1]

History of the company

Novopharm was founded by pharmacist and businessman Leslie Dan in 1965. Its first product was the generic antibiotic, tetracycline. The company expanded to become Canada's second largest generic drug manufacturer and it also owned sites in the US and Hungary by the mid 1990s.[2] In Hungary, the company owned a small subsidiary called Human. In the US, it operated a distribution center in Schaumburg, Illinois, although all products continued to be made in Canada. Novopharm was the first generic company to market a generic version of Glaxo's Zantac for the US market.[3]

Novopharm remained privately held by the Dan family until 2000, when it was acquired by Teva Pharmaceuticals.[4][5] At the time, Novopharm was Canada's second largest drug manufacturer.[6] Teva, a generic drug manufacturer based in Jerusalem, Israel, was already one of the world's largest generic manufacturers. The acquisition made Teva the largest generic drug company in North America.

Facilities and markets served

Teva Canada maintains several facilities in the Toronto area, including its headquarters in Scarborough, a specialized antibiotics manufacturing facility in Markham, and their main manufacturing facility in Stouffville.[7] Their headquarters is also home to their main laboratory, packaging, and warehousing operations. According to their promotional brochure, their Markham site, which underwent a major expansion in 2004,[8] is the largest antibiotic manufacturing facility in North America.[9]

In addition to the Canadian drug market, products manufactured by Teva Canada are exported worldwide[8] under the Teva name.

References

  1. "Novopharm Limited becomes Teva Canada Limited". CNW. February 16, 2010. Retrieved 2010-04-13.
  2. "Teva refuerza su posición con adquisiciones. (Teva Pharmaceutical Industries Ltd.)" . Chain Drug Review . 25 de septiembre de 2000. Consultado el 8 de mayo de 2009 .
  3. "Un fabricante de Zantac genérico gana una ronda de financiación de Glaxo" . The New York Times . Bloomberg Business News. 8 de julio de 1996. Consultado el 8 de mayo de 2009 .
  4. "Teva completa la adquisición de Novopharm" . Jerusalem Post ( edición en línea). 6 de abril de 2000. Archivado del original el 21 de octubre de 2012. Consultado el 8 de mayo de 2009 . 
  5. "Teva completa la adquisición de Novopharm" . Business Wire. 1 de febrero de 2000. Consultado el 8 de mayo de 2009 .
  6. "Teva anuncia la finalización de la adquisición de Novopharm" . Business Wire . 5 de abril de 2000. Consultado el 8 de mayo de 2009 .
  7. "Instalaciones" . Nuestra empresa . TEVA Canadá . Consultado el 10 de octubre de 2010 .{{cite web}}: CS1 maint: servicio de archivado obsoleto ( enlace )
  8. 1 2 "Novopharm invertirá en la instalación" . icis.com. 15 de marzo de 2004. Consultado el 8 de mayo de 2009 .
  9. "Su ventaja global - Teva Novopharm" . Teva-Novopharm. Archivado del original el 30 de marzo de 2009. Consultado el 8 de mayo de 2009 .